重组干扰素α2b治疗小儿病毒感染性腹泻疗效观察

Effect of recombinant interferon α2b on children with virus infectious diarrhea

目的观察重组干扰素α2b治疗小儿病毒感染性腹泻疗效。方法将84例病毒感染性腹泻患儿分为治疗组45例用干扰素α2b治疗,对照组39例用黄连素治疗,疗程均5天。结果治疗组显效17例,有效19例,无效9例,总有效率80%;对照组显效7,有效13例,无效19例,总有效率51.3%。两组比较有显著差异性(P<0.05)。结论重组干扰素α2b是治疗小儿病毒感染性腹泻的有效药物,其疗效与年龄等因素有关。

Aim To observe the effect of Recombinant interferon et 2b on treating children＇ s virus infectious diarrhea. Methods A total of 84 patients were randomly divided into two groups ：45 patients in the treatment group received interferon α2b, 39 patients as the control group received Berberine Hydrochloride, both for 5 days. Results Effective rate of the treatment group was 80%, and that of the control group was 51.3 % . There was statistically significant difference （P 〈 0.05）. Conclusion Recombinant interferon α 2b is effective for treating children＇ s virus infectiours diarrhea. The effect is related to age.